Saturday, November 22, 2014
FAIRFIELD-SUISUN, CALIFORNIA
99 CENTS

Genentech Alzheimer’s drug misses goals in studies

By
From page A5 | July 17, 2014 |

An experimental drug from the biotech company Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer’s disease, but showed some promise in the least-impaired participants who received a higher dose.

Pneumonia and deaths were more common among those receiving the drug, but researchers downplayed that. Study leader Dr. Jeffrey Cummings of the Cleveland Clinic said none of the deaths seemed due to the drug and pneumonia occurred at a rate to be expected in older people.

“We’re very encouraged” by the hint of benefit for patients with milder dementia and will talk with regulators about next steps for the drug, crenezumab (cruh-NEZ-oo-mab), said a Genentech scientist, Dr. Carole Ho. The results fit with other evidence suggesting that treating earlier in the course of the disease is better, she said.

Results were revealed Wednesday at the Alzheimer’s Association International Conference in Copenhagen.

They are the latest mixed bag on treatments aimed at clearing away the sticky amyloid plaques clogging Alzheimer’s patients’ brains. About 35 million people worldwide have Alzheimer’s, the most common form of dementia. There is no cure and current treatments only temporarily ease symptoms.

Last year, an Eli Lilly & Co. medicine, solanezumab, that also sought to clear away amyloid missed main goals in two studies but combined results suggested it might help people with milder disease. It’s in further study now. Before that, bapineuzumab, a similar drug being developed by Pfizer Inc. and Johnson & Johnson, showed promise in mid-stage testing but flopped in larger, more definitive trials.

The Genentech drug has been closely watched because it targets amyloid more broadly than the other drugs do, and the California-based company has a long track record of success with many biological medicines against cancer.

Mid-stage studies aim to give some idea of safety and whether the drug is effective enough to advance to larger, more definitive studies aimed at winning market approval.

In one study, 431 patients ages 50 to 80 with mild to moderate Alzheimer’s were given crenezumab or dummy drug as shots every two weeks, or as a higher dose in infusions every four weeks for 17 months. No significant difference was seen among the groups on two widely used measures of thinking and functioning skills.

However, the 70 most mildly impaired participants who received the higher dose declined 35 percent less on the cognitive measure than the 33 mildly impaired people given dummy infusions. The difference was about 3.5 points on the roughly 70-point scale — “equivalent to six or nine months” of delay in decline, Cummings said.

This result isn’t definitive, though, and can only be considered a signal worth exploring in future research because it didn’t involve the whole group tested. And even in this mildly impaired group, the drug did not improve the second measure, ability to function in daily life.

In the second study, 73 people who showed amyloid plaques on brain imaging also were given crenezumab or dummy shots or infusions. The main outcome — levels of amyloid seen on brain imaging after treatment — will be presented at a medical conference in November. Results on cognitive function seem to mirror those in the larger study, Cummings said.

Five people given crenezumab died — one from sudden death, two from respiratory failure, one from pneumonia and one from worsening Alzheimer’s.

“We believe that the safety profile is acceptable,” because deaths do not seem related to the drug, Genentech’s Ho said. “It is not a show stopper.”

Genentech and its corporate parent, Switzerland-based Roche Holding AG, paid for the study and Cummings is a paid adviser to Genentech.

In a statement Wednesday, the Alzheimer’s Association noted that crenezumab was being tested in another study aimed at preventing the disease, and said the new results give hope it will be more successful in that setting.

___

Online:

National Institute on Aging: http://www.nia.nih.gov/Alzheimers

Patient, family info: http://www.alzheimers.gov/

Alzheimer’s Association: http://www.alz.org

 

The Associated Press

The Associated Press

LEAVE A COMMENT

Discussion | No comments

The Daily Republic does not necessarily condone the comments here, nor does it review every post. Read our full policy

.

US / World

House intel panel debunks many Benghazi theories

By The Associated Press | From Page: A1, 7 Comments

 
A look at how FDA-approved robotic leg braces work

By The Associated Press | From Page: A1

Marine with robotic leg braces gets Bronze Star

By The Associated Press | From Page: A1, 1 Comment | Gallery

 
Oregon festival’s giant nutcracker: 41 feet

By The Associated Press | From Page: A2

San Francisco window washer falls onto moving car

By The Associated Press | From Page: A3 | Gallery

 
Zookeepers had safety concerns before gorilla died

By The Associated Press | From Page: A4

California storms bring scattered rain, mudslides

By The Associated Press | From Page: A4 | Gallery

 
Judge declares wrongly convicted woman innocent

By The Associated Press | From Page: A4 | Gallery

$139M deal reached in school molestation case

By The Associated Press | From Page: A4

 
Agency rejects solar project in Silurian Valley

By The Associated Press | From Page: A5

Senate leader lays off dozens of office employees

By The Associated Press | From Page: A5, 1 Comment

 
UC expands legal services for immigrant students

By The Associated Press | From Page: A5

Man pleads not guilty to emailing nudies of ex

By The Associated Press | From Page: A5

 
Stymied? Republicans seek immigration response

By The Associated Press | From Page: A5

LA animal shelter slashes prices on 100 pets

By The Associated Press | From Page: A5 | Gallery

 
Iran nuke talks stalled, despite Kerry efforts

By The Associated Press | From Page: A10

Biden urges Russia to uphold east Ukraine truce

By The Associated Press | From Page: A10

 
Police: 3-year-old set fire that killed his family

By The Associated Press | From Page: A10

93-year-old woman marks 75 years with same company

By The Associated Press | From Page: A10

 
UK police spied on reporters for years, docs show

By The Associated Press | From Page: A10

Agency: Schools helped Lanza’s mom ‘appease’ him

By The Associated Press | From Page: A10

 
Bandits in Guinea steal suspected Ebola blood

By The Associated Press | From Page: A10

With snow still piled high, Buffalo faces flooding

By The Associated Press | From Page: A10

 
.

Opinion

 
Editorial Cartoons: Nov. 22, 2014

By Daily Republic Syndicated Content | From Page: A8

 
Batson column falls short of truth

By Letter to the Editor | From Page: A8, 40 Comments

.

Living

Community Calendar: Nov. 22, 2014

By Susan Hiland | From Page: A2

 
Today in History: Nov. 22, 2014

By The Associated Press | From Page: A2

My sister kicked Mom out of her house and won’t let her have the car

By Kathy Mitchell and Marcy Sugar | From Page: A7

 
Horoscopes: Nov. 22, 2014

By Holiday Mathis | From Page: A7

Blanket drive for homeless gets help from Colts player

By The Associated Press | From Page: B8

 
.

Entertainment

Bill Cosby show set for Vegas casino canceled

By The Associated Press | From Page: B9

 
Matt Czuchry says ‘Good Wife’ arc is at right time

By The Associated Press | From Page: B9

‘Queen Latifah Show’ to end after its 2nd season

By The Associated Press | From Page: B9

 
TVGrid

By Daily Republic Syndicated Content | From Page: B9

.

Sports

Vacaville downs Del Oro to advance to section semis

By Nick DeCicco | From Page: B1

 
Sparano savors 1st win with Raiders

By The Associated Press | From Page: B1

 
Ibanez, Cash, Wakamatsu finalists to manage Rays

By The Associated Press | From Page: B2

 
Federal judge denies sports betting in New Jersey

By The Associated Press | From Page: B2

JC women’s basketball: Solano advances to tourney title game

By Daily Republic staff | From Page: B2

 
Ciganda, Granada tied for lead at LPGA finale

By The Associated Press | From Page: B2

Sharks trade Demers to Stars for Dillon

By The Associated Press | From Page: B2

 
NFL will hear Adrian Peterson’s appeal Dec. 2

By The Associated Press | From Page: B2

49ers’ Dorsey is out of Sunday’s game against Redskins

By The Associated Press | From Page: B2

 
France levels tie against Switzerland in Davis Cup

By The Associated Press | From Page: B2

 
This date in sports history for Saturday, Nov. 22, 2014

By The Associated Press | From Page: B3

.

Business

Toyota recalls nearly 423K Lexuses for fuel leaks

By The Associated Press | From Page: B4

 
Ford’s new F-150 to get 26 mpg, tops among pickups

By The Associated Press | From Page: B4, 1 Comment | Gallery

CEOs in 10 big mergers to get $430M: Equilar study

By The Associated Press | From Page: B4

 
California unemployment unchanged at 7.3 percent

By The Associated Press | From Page: B4

White House: Immigration steps would boost wages

By The Associated Press | From Page: B4

 
.

Obituaries

.

Comics

Wizard of Id

By Daily Republic Syndicated Content | From Page: A6

 
For Better or Worse

By Daily Republic Syndicated Content | From Page: A6

B.C.

By Daily Republic Syndicated Content | From Page: A6

 
Baldo

By Daily Republic Syndicated Content | From Page: A6

Rose is Rose

By Daily Republic Syndicated Content | From Page: A6

 
Beetle Bailey

By Daily Republic Syndicated Content | From Page: A6

Blondie

By Daily Republic Syndicated Content | From Page: A6

 
Sally Forth

By Daily Republic Syndicated Content | From Page: A6

Zits

By Daily Republic Syndicated Content | From Page: A6

 
Pickles

By Daily Republic Syndicated Content | From Page: A6

Frank and Ernest

By Daily Republic Syndicated Content | From Page: A6

 
Peanuts

By Daily Republic Syndicated Content | From Page: A6

Garfield

By Daily Republic Syndicated Content | From Page: A6

 
Get Fuzzy

By Daily Republic Syndicated Content | From Page: A6

Dilbert

By Daily Republic Syndicated Content | From Page: A6

 
Baby Blues

By Daily Republic Syndicated Content | From Page: A6

Bridge

By Daily Republic Syndicated Content | From Page: A7

 
Sudoku

By Daily Republic Syndicated Content | From Page: A7

Cryptoquote

By Daily Republic Syndicated Content | From Page: A7

 
Crossword

By Daily Republic Syndicated Content | From Page: A7

Word Sleuth

By Daily Republic Syndicated Content | From Page: A7

 
.

Home Seller 11/22/14

Ask a Designer: from clutter to decor

By The Associated Press | From Page: HSR2

Real estate transactions for Nov. 22, 2014

By Maureen Fissolo | From Page: HSR3

US 30-year mortgage rates drop to 3.99 percent

By The Associated Press | From Page: HSR3